{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T21:25:46Z","timestamp":1782595546418,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T00:00:00Z","timestamp":1529107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,2,8]]},"DOI":"10.1007\/s00784-018-2519-6","type":"journal-article","created":{"date-parts":[[2018,6,16]],"date-time":"2018-06-16T19:28:02Z","timestamp":1529177282000},"page":"947-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-5786","authenticated-orcid":false,"given":"Ola M.","family":"Ezzatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman M.","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,16]]},"reference":[{"key":"2519_CR1","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1365-4632.2009.04062.x","volume":"48","author":"JS Lehman","year":"2009","unstructured":"Lehman JS, Tollefson MM, Gibson LE (2009) Lichen planus. Int J Dermatol 48:682\u2013694. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04062.x","journal-title":"Int J Dermatol"},{"key":"2519_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0030-4220(91)90007-Y","volume":"72","author":"S Silverman","year":"1991","unstructured":"Silverman S, Gorsky M, Lozada-Nur F, Giannotti K (1991) A prospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 72:665\u2013670","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"2519_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1067\/mjd.2002.120452","volume":"46","author":"D Eisen","year":"2002","unstructured":"Eisen D (2002) The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 46:207\u2013214. https:\/\/doi.org\/10.1067\/mjd.2002.120452","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1601-0825.2005.01142.x","volume":"11","author":"D Eisen","year":"2005","unstructured":"Eisen D, Carrozzo M, Bagan Sebastian J-V, Thongprasom K (2005) Number V oral lichen planus: clinical features and management. Oral Dis 11:338\u2013349. https:\/\/doi.org\/10.1111\/j.1601-0825.2005.01142.x","journal-title":"Oral Dis"},{"key":"2519_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/154411130201300405","volume":"13","author":"PB Sugerman","year":"2002","unstructured":"Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13:350\u2013365. https:\/\/doi.org\/10.1177\/154411130201300405","journal-title":"Crit Rev Oral Biol Med"},{"key":"2519_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1600-0714.2010.00946.x","volume":"39","author":"MR Roopashree","year":"2010","unstructured":"Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus\u2014a review. J Oral Pathol Med 39:729\u2013734. https:\/\/doi.org\/10.1111\/j.1600-0714.2010.00946.x","journal-title":"J Oral Pathol Med"},{"key":"2519_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","volume":"36","author":"S Warnakulasuriya","year":"2007","unstructured":"Warnakulasuriya S, Johnson NW, van der Waal I (2007) Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36:575\u2013580. https:\/\/doi.org\/10.1111\/j.1600-0714.2007.00582.x","journal-title":"J Oral Pathol Med"},{"key":"2519_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14219\/jada.2013.10","volume":"145","author":"SG Fitzpatrick","year":"2014","unstructured":"Fitzpatrick SG, Hirsch SA, Gordon SC (2014) The malignant transformation of oral lichen planus and oral lichenoid lesions. J Am Dent Assoc 145:45\u201356. https:\/\/doi.org\/10.14219\/jada.2013.10","journal-title":"J Am Dent Assoc"},{"key":"2519_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.5005\/jp-journals-10024-1914","volume":"17","author":"F Agha-Hosseini","year":"2016","unstructured":"Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M-S (2016) Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract 17:692\u2013701","journal-title":"J Contemp Dent Pract"},{"key":"2519_CR10","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.oraloncology.2009.01.009","volume":"45","author":"A Bermejo-Fenoll","year":"2009","unstructured":"Bermejo-Fenoll A, Sanchez-Siles M, L\u00f3pez-Jornet P, Camacho-Alonso F, Salazar-Sanchez N (2009) Premalignant nature of oral lichen planus. A retrospective study of 550 oral lichen planus patients from South-Eastern Spain. Oral Oncol 45:e54\u2013e56. https:\/\/doi.org\/10.1016\/j.oraloncology.2009.01.009","journal-title":"Oral Oncol"},{"key":"2519_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.oraloncology.2011.10.004","volume":"48","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Filho MS, N\u00f6r JE (2012) The biology of head and neck cancer stem cells. Oral Oncol 48:1\u20139","journal-title":"Oral Oncol"},{"key":"2519_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1177\/0022034511423393","volume":"91","author":"S Krishnamurthy","year":"2012","unstructured":"Krishnamurthy S, Nor JE (2012) Head and neck Cancer stem cells. J Dent Res 91:334\u2013340. https:\/\/doi.org\/10.1177\/0022034511423393","journal-title":"J Dent Res"},{"key":"2519_CR13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1089\/scd.2008.0338","volume":"18","author":"Y Wu","year":"2009","unstructured":"Wu Y, Wu PY (2009) CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 18:1127\u20131134. https:\/\/doi.org\/10.1089\/scd.2008.0338","journal-title":"Stem Cells Dev"},{"key":"2519_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/01.mlg.0000251586.15299.35","volume":"117","author":"L Zhou","year":"2007","unstructured":"Zhou L, Wei X, Cheng L, Tian J, Jiang JJ (2007) CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 117:455\u2013460. https:\/\/doi.org\/10.1097\/01.mlg.0000251586.15299.35","journal-title":"Laryngoscope"},{"key":"2519_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/hed.21896","volume":"34","author":"G Ravindran","year":"2012","unstructured":"Ravindran G, Devaraj H (2012) Aberrant expression of CD133 and musashi-1 in preneoplastic and neoplastic human oral squamous epithelium and their correlation with clinicopathological factors. Head Neck 34:1129\u20131135. https:\/\/doi.org\/10.1002\/hed.21896","journal-title":"Head Neck"},{"key":"2519_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.anndiagpath.2013.06.004","volume":"17","author":"L Sun","year":"2013","unstructured":"Sun L, Feng J, Ma L, Liu W, Zhou Z (2013) CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Ann Diagn Pathol 17:486\u2013489. https:\/\/doi.org\/10.1016\/j.anndiagpath.2013.06.004","journal-title":"Ann Diagn Pathol"},{"key":"2519_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0733-8635(02)00067-0","volume":"21","author":"D Eisen","year":"2003","unstructured":"Eisen D (2003) The clinical manifestations and treatment of oral lichen planus. Dermatol Clin 21:79\u201389","journal-title":"Dermatol Clin"},{"key":"2519_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/09629359891126","volume":"7","author":"A Ahluwalia","year":"1998","unstructured":"Ahluwalia A (1998) Topical glucocorticoids and the skin\u2014mechanisms of action: an update. Mediat Inflamm 7:183\u2013193. https:\/\/doi.org\/10.1080\/09629359891126","journal-title":"Mediat Inflamm"},{"key":"2519_CR19","first-page":"123","volume":"162","author":"DA Fisher","year":"1995","unstructured":"Fisher DA (1995) Adverse effects of topical corticosteroid use. West J Med 162:123\u2013126","journal-title":"West J Med"},{"key":"2519_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.0906-6705.2004.00269.x","volume":"13","author":"M Grassberger","year":"2004","unstructured":"Grassberger M, Steinhoff M, Schneider D, Luger TA (2004) Pimecrolimus\u2014an anti-inflammatory drug targeting the skin. Exp Dermatol 13:721\u2013730. https:\/\/doi.org\/10.1111\/j.0906-6705.2004.00269.x","journal-title":"Exp Dermatol"},{"key":"2519_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000095289","volume":"141","author":"A Stuetz","year":"2006","unstructured":"Stuetz A, Baumann K, Grassberger M, Wolff K, Meingassner JG (2006) Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus. Int Arch Allergy Immunol 141:199\u2013212","journal-title":"Int Arch Allergy Immunol"},{"key":"2519_CR22","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/archderm.143.4.472","volume":"143","author":"T Passeron","year":"2007","unstructured":"Passeron T, Lacour J-P, Fontas E, Ortonne J-P (2007) Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol 143:472\u2013476. https:\/\/doi.org\/10.1001\/archderm.143.4.472","journal-title":"Arch Dermatol"},{"key":"2519_CR23","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/j.1365-2133.2008.08726.x","volume":"159","author":"T Volz","year":"2008","unstructured":"Volz T, Caroli U, L\u00fcdtke H, Br\u00e4utigam M, Kohler-Sp\u00e4th H, R\u00f6cken M, Biedermann T (2008) Pimecrolimus cream 1% in erosive oral lichen planus\u2014a prospective randomized double-blind vehicle-controlled study. Br J Dermatol 159:936\u2013941. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08726.x","journal-title":"Br J Dermatol"},{"key":"2519_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1902\/jop.2005.76.4.627","volume":"76","author":"JC Swift","year":"2005","unstructured":"Swift JC, Rees TD, Plemons JM, Hallmon WW, Wright JC (2005) The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus. J Periodontol 76:627\u2013635. https:\/\/doi.org\/10.1902\/jop.2005.76.4.627","journal-title":"J Periodontol"},{"key":"2519_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jaad.2007.06.022","volume":"57","author":"F Gorouhi","year":"2007","unstructured":"Gorouhi F, Solhpour A, Beitollahi JM, Afshar S, Davari P, Hashemi P, Nassiri Kashani M, Firooz A (2007) Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol 57:806\u2013813. https:\/\/doi.org\/10.1016\/j.jaad.2007.06.022","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2133.2012.10821.x","volume":"166","author":"G Lodi","year":"2012","unstructured":"Lodi G, Carrozzo M, Furness S, Thongprasom K (2012) Interventions for treating oral lichen planus: a systematic review. Br J Dermatol 166:938\u2013947. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10821.x","journal-title":"Br J Dermatol"},{"key":"2519_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1177\/1203475415591936","volume":"19","author":"B Sotoodian","year":"2015","unstructured":"Sotoodian B, Lo J, Lin A (2015) Efficacy of topical calcineurin inhibitors in oral lichen planus. J Cutan Med Surg 19:539\u2013545. https:\/\/doi.org\/10.1177\/1203475415591936","journal-title":"J Cutan Med Surg"},{"key":"2519_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/odi.12634","volume":"23","author":"S Gupta","year":"2017","unstructured":"Gupta S, Ghosh S, Gupta S (2017) Interventions for the management of oral lichen planus: a review of the conventional and novel therapies. Oral Dis 23:1029\u20131042. https:\/\/doi.org\/10.1111\/odi.12634","journal-title":"Oral Dis"},{"key":"2519_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.tripleo.2009.02.020","volume":"107","author":"M Rad","year":"2009","unstructured":"Rad M, Hashemipoor MA, Mojtahedi A, Zarei MR, Chamani G, Kakoei S, Izadi N (2009) Correlation between clinical and histopathologic diagnoses of oral lichen planus based on modified WHO diagnostic criteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:796\u2013800. https:\/\/doi.org\/10.1016\/j.tripleo.2009.02.020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"2519_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.archger.2003.10.005","volume":"38","author":"N Pendleton","year":"2004","unstructured":"Pendleton N, Clague JE, Horan MA, Rabbitt PMA, Jones M, Coward R, Lowe C, McInnes L (2004) Concordance of Cornell medical index self-reports to structured clinical assessment for the identification of physical health status. Arch Gerontol Geriatr 38:261\u2013269. https:\/\/doi.org\/10.1016\/j.archger.2003.10.005","journal-title":"Arch Gerontol Geriatr"},{"key":"2519_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1034\/j.1600-0714.2003.00130.x","volume":"32","author":"K Thongprasom","year":"2003","unstructured":"Thongprasom K, Luengvisut P, Wongwatanakij A, Boonjatturus C (2003) Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med 32:315\u2013322","journal-title":"J Oral Pathol Med"},{"key":"2519_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3959(76)90113-5","volume":"2","author":"J Scott","year":"1976","unstructured":"Scott J, Huskisson EC (1976) Graphic representation of pain. Pain 2:175\u2013184. https:\/\/doi.org\/10.1016\/0304-3959(76)90113-5","journal-title":"Pain"},{"key":"2519_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1067\/mjd.2002.120922","volume":"47","author":"AM Hegarty","year":"2002","unstructured":"Hegarty AM, Hodgson TA, Lewsey JD, Porter SR (2002) Fluticasone propionate spray and betamethasone sodium phosphate mouth rinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol 47:271\u2013279. https:\/\/doi.org\/10.1067\/mjd.2002.120922","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2007.11.022","volume":"58","author":"AK Malhotra","year":"2008","unstructured":"Malhotra AK, Khaitan BK, Sethuraman G, Sharma VK (2008) Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: a randomized comparative study. J Am Acad Dermatol 58:596\u2013602. https:\/\/doi.org\/10.1016\/j.jaad.2007.11.022","journal-title":"J Am Acad Dermatol"},{"key":"2519_CR35","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.0007-0963.2004.05884.x","volume":"150","author":"J Dissemond","year":"2004","unstructured":"Dissemond J, Schr\u00f6ter S, Franckson T et al (2004) Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus [9]. Br J Dermatol 150:782\u2013784","journal-title":"Br J Dermatol"},{"issue":"8","key":"2519_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1468-3083.2007.02539.x","volume":"22","author":"J Dissemond","year":"2008","unstructured":"Dissemond J (2008) Pimecrolimus in an adhesive ointment is safe and effective in long-term treatment for oral lichen planus. J Eur Acad Dermatol Venereol 22(8):1009\u20131011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2519_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1600-0714.2011.01099.x","volume":"41","author":"SS Ibrahim","year":"2012","unstructured":"Ibrahim SS, Hazzaa HH (2012) Topical pimecrolimus effect on Fas inducing apoptosis in oral lichen planus: a clinical immunohistochemical study. J Oral Pathol Med 41:315\u2013321. https:\/\/doi.org\/10.1111\/j.1600-0714.2011.01099.x","journal-title":"J Oral Pathol Med"},{"key":"2519_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","volume":"63","author":"MJ Herold","year":"2006","unstructured":"Herold MJ, McPherson KG, Reichardt HM (2006) Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63:60\u201372","journal-title":"Cell Mol Life Sci"},{"key":"2519_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2340\/00015555-0070","volume":"86","author":"R Laeijendecker","year":"2006","unstructured":"Laeijendecker R, Tank B, Dekker SK, Neumann H a M (2006) A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 86:227\u2013229. https:\/\/doi.org\/10.2340\/00015555-0070","journal-title":"Acta Derm Venereol"},{"key":"2519_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jdv.12128","volume":"28","author":"PG Arduino","year":"2014","unstructured":"Arduino PG, Carbone M, Della Ferrera F, Elia A, Conrotto D, Gambino A, Comba A, Calogiuri PL, Broccoletti R (2014) Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized double-blind controlled study. J Eur Acad Dermatol Venereol 28:475\u2013482. https:\/\/doi.org\/10.1111\/jdv.12128","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2519_CR41","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1398-9995.2005.00798.x","volume":"60","author":"D Simon","year":"2005","unstructured":"Simon D, Vassina E, Yousefi S, Braathen LR, Simon HU (2005) Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. Allergy 60:944\u2013951. https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00798.x","journal-title":"Allergy"},{"key":"2519_CR42","doi-asserted-by":"publisher","unstructured":"Kalthoff FS, Chung J, Musser P, Stuetz a (2003) Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol 133:350\u2013359. doi: https:\/\/doi.org\/10.1046\/j.1365-2249.2003.02225.x","DOI":"10.1046\/j.1365-2249.2003.02225.x"},{"key":"2519_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000102119","volume":"215","author":"T Luger","year":"2007","unstructured":"Luger T, Paul C (2007) Potential new indications of topical calcineurin inhibitors. Dermatology 215:45\u201354","journal-title":"Dermatology"},{"key":"2519_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1087-0024.2004.09310.x","volume":"9","author":"D Tudor","year":"2004","unstructured":"Tudor D, Locke M, Owen-Jones E, Mackenzie IC (2004) Intrinsic patterns of behavior of epithelial stem cells. J Investig Dermatol Symp Proc 9:208\u2013214. https:\/\/doi.org\/10.1111\/j.1087-0024.2004.09310.x","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2519_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.oraloncology.2003.08.016","volume":"40","author":"MA Gonz\u00e1lez-Moles","year":"2004","unstructured":"Gonz\u00e1lez-Moles MA, Bravo M, Ruiz-Avila I et al (2004) Adhesion molecule CD44 expression in non-tumour epithelium adjacent to tongue cancer. Oral Oncol 40:281\u2013286","journal-title":"Oral Oncol"},{"key":"2519_CR46","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/hed.21315","volume":"32","author":"MR Clay","year":"2010","unstructured":"Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME (2010) Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32:1195\u20131201. https:\/\/doi.org\/10.1002\/hed.21315","journal-title":"Head Neck"},{"key":"2519_CR47","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbcan.2010.06.004","volume":"1806","author":"V Richard","year":"2010","unstructured":"Richard V, Pillai MR (2010) The stem cell code in oral epithelial tumorigenesis: \u201cthe cancer stem cell shift hypothesis\u201d. Biochim Biophys Acta 1806:146\u2013162. https:\/\/doi.org\/10.1016\/j.bbcan.2010.06.004","journal-title":"Biochim Biophys Acta"},{"key":"2519_CR48","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.oraloncology.2013.04.002","volume":"49","author":"MA Gonz\u00e1lez-Moles","year":"2013","unstructured":"Gonz\u00e1lez-Moles MA, Scully C, Ruiz-\u00c1vila I, Plaza-Campillo JJ (2013) The cancer stem cell hypothesis applied to oral carcinoma. Oral Oncol 49:738\u2013746. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.04.002","journal-title":"Oral Oncol"},{"key":"2519_CR49","first-page":"89","volume":"50","author":"X Wang","year":"2015","unstructured":"Wang X, Tang G, Sun H (2015) Effect of hypoxia on the proliferation and expressions of hypoxia-inducible factor-1\u03b1, vascular endothelial growth factor and matrix metalloproteinase-9 in keratinocytes obtained from oral lichen planus lesions. Zhonghua Kou Qiang Yi Xue Za Zhi 50:89\u201394","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"2519_CR50","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00784-013-0920-8","volume":"17","author":"CA de Carvalho Fraga","year":"2013","unstructured":"de Carvalho Fraga CA, Alves LR, Marques-Silva L, de Sousa AA, Jorge ASB, de Jesus SF, Vilela DN, Pinheiro UB, Jones KM, de Paula AMB, Guimar\u00e3es ALS (2013) High HIF-1\u03b1 expression genotypes in oral lichen planus. Clin Oral Investig 17:2011\u20132015. https:\/\/doi.org\/10.1007\/s00784-013-0920-8","journal-title":"Clin Oral Investig"},{"key":"2519_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/ijo.2011.1207","volume":"40","author":"H Iida","year":"2012","unstructured":"Iida H, Suzuki M, Goitsuka R, Ueno H (2012) Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3\/4 and SOX2. Int J Oncol 40:71\u201379. https:\/\/doi.org\/10.3892\/ijo.2011.1207","journal-title":"Int J Oncol"},{"key":"2519_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1365-3083.2006.01835.x","volume":"64","author":"M Holm","year":"2006","unstructured":"Holm M, Kvistgaard H, Dahl C, Andersen HB, Hansen TK, Schi\u00f8tz PO, Junker S (2006) Modulation of chemokine gene expression in CD133+ cord blood-derived human mast cells by cyclosporin a and dexamethasone. Scand J Immunol 64:571\u2013579. https:\/\/doi.org\/10.1111\/j.1365-3083.2006.01835.x","journal-title":"Scand J Immunol"},{"key":"2519_CR53","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.4049\/jimmunol.181.3.1665","volume":"181","author":"A Walczak-Drzewiecka","year":"2008","unstructured":"Walczak-Drzewiecka A, Ratajewski M, Wagner W, Dastych J (2008) HIF-1alpha is up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol 181:1665\u20131672","journal-title":"J Immunol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-018-2519-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-018-2519-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T15:18:39Z","timestamp":1607959119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-018-2519-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,16]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,8]]}},"alternative-id":["2519"],"URL":"https:\/\/doi.org\/10.1007\/s00784-018-2519-6","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,16]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}